Plasma Brain-Derived Neurotrophic Factor as a Biomarker for the Main Types of Mild Neurocognitive Disorders and Treatment Efficacy: A Preliminary Study

Decreased levels of brain-derived neurotrophic factor (BDNF) are assumed to play a crucial role in the pathophysiology of mild neurocognitive disorders (MNCDs). In this study, we compared plasma BDNF levels (at baseline and after two months of treatment with escitalopram) in patients with the main t...

Descripción completa

Detalles Bibliográficos
Autores principales: Levada, Oleg A., Cherednichenko, Nataliya V., Trailin, Andriy V., Troyan, Alexandra S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997080/
https://www.ncbi.nlm.nih.gov/pubmed/27597800
http://dx.doi.org/10.1155/2016/4095723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997080/
https://www.ncbi.nlm.nih.gov/pubmed/27597800
http://dx.doi.org/10.1155/2016/4095723

Ejemplares similares